Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)
This study has been completed.
Study NCT00569699 Information provided by Taiho Pharmaceutical Co., Ltd.
First Received on December 5, 2007. Last Updated on November 1, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Neoplasms by Site
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Angiogenesis Modulating Agents
Physiological Effects of Drugs
Sponsors listed in this trial
Taiho Pharmaceutical Co., Ltd.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers